Prilocaine: Difference between revisions
No edit summary |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 11: | Line 11: | ||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: B | ||
*Lactation: | *Lactation: Unknown | ||
*Renal Dosing | *Renal Dosing | ||
**Adult | **Adult | ||
| Line 22: | Line 22: | ||
==Contraindications== | ==Contraindications== | ||
*Allergy to class/drug | *Allergy to class/drug | ||
*Methemoglobinemia | |||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*[[Local anesthetic systemic toxicity]] | |||
*Confusion, disorientation | |||
*Anaphylaxis | |||
*Seizures | |||
*Status asthmaticus | |||
===Common=== | ===Common=== | ||
*Anxiety, restlessness | |||
*Dizziness | |||
*Twitching, shivering | |||
*Edema | |||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: | *Half-life: 10-150 min | ||
*Metabolism: | *Metabolism: hepatic and renal | ||
*Excretion: | *Excretion: urinary | ||
*Mechanism of Action: | *Mechanism of Action: Local anesthetic; prevents generation/conduction of nerve impulses by reducing sodium permeability and increasing action potential threshold | ||
==See Also== | ==See Also== | ||
Latest revision as of 21:56, 23 September 2019
General
- Type: Local anesthetics
- Dosage Forms:
- Common Trade Names:
Maximum Doses of Anesthetic Agents
| Agent | Without Epinephrine | With Epinephrine | Duration | Notes |
| Lidocaine | 5 mg/kg (max 300mg) | 7 mg/kg (max 500mg) | 30-90 min |
|
| Mepivicaine | 7 mg/kg | 8 mg/kg | ||
| Bupivicaine | 2.5 mg/kg (max 175mg) | 3 mg/kg (max 225mg) | 6-8 hr |
|
| Ropivacaine | 3 mg/kg | |||
| Prilocaine | 6 mg/kg | |||
| Tetracaine | 1 mg/kg | 1.5 mg/kg | 3hrs (10hrs with epi) | |
| Procaine | 7 mg/kg | 10 mg/kg | 30min (90min with epi) |
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating: B
- Lactation: Unknown
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
- Methemoglobinemia
Adverse Reactions
Serious
- Local anesthetic systemic toxicity
- Confusion, disorientation
- Anaphylaxis
- Seizures
- Status asthmaticus
Common
- Anxiety, restlessness
- Dizziness
- Twitching, shivering
- Edema
Pharmacology
- Half-life: 10-150 min
- Metabolism: hepatic and renal
- Excretion: urinary
- Mechanism of Action: Local anesthetic; prevents generation/conduction of nerve impulses by reducing sodium permeability and increasing action potential threshold
